RxDoctor Payments Data

Frank Wermeling, MD

Plastic Surgery · Louisville, KYNPI 1861752909

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (45.5%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by RTI Surgical, Inc at 34.7% of the total.

$7,416in general payments, 2019–2025

Across 71 payments — averaging $104.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • RTI Surgical, Inc$3K
  • Integra Lifesciences Corporation$2K
  • Medical Device Business Services, Inc.$1K
  • AbbVie$820
  • Sientra, Inc.$342
  • Mentor Worldwide LLC$306
  • plus $279 from 6 others

What the payments were for

  • Consulting fees$1,65022%
  • Speaking & faculty fees$1,20016%
  • Travel & lodging$1,18916%
  • Food & beverage$3,37846%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,416 in reported general payments places this provider in the 75th percentile of 48 plastic surgery providers in Kentucky.

See all plastic surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$41,394
Medicare patients
71
Services billed
110

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron48$287
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen44$156
Gabapentin37$115

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →